Skip to main content

Peer Review reports

From: Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13

Original Submission
18 Jul 2022 Submitted Original manuscript
27 Jul 2022 Author responded Author comments - Koichi Okamura
28 Jul 2022 Reviewed Reviewer Report - Rene Westhovens
15 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 2
27 Jul 2022 Submitted Manuscript version 2
Publishing
26 Aug 2022 Editorially accepted
7 Dec 2022 Article published 10.1186/s41927-022-00304-9

You can find further information about peer review here.

Back to article page